Immuno-Oncology: Mustbio

About this session

Mustbio is a biotechnology company developing first-in-class and best-in-class tumor-selective immuno-cytokines to advance cancer immunotherapy. Our mission is to harness the power of the immune system by overcoming the limitations of conventional cytokine therapies, including narrow therapeutic windows, systemic toxicity, and limited efficacy in immunologically "cold" tumors. Founded by experts in biologics and drug development, Mustbio is committed to delivering transformative immuno-oncology therapies for unmet medical needs.

Speaker

• JP

  Jun-Eui Park

  Head of BD & Strategy · Mustbio

  Speaker